{"nct_id":"NCT00293111","title":"Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM)","status":"TERMINATED","status_verified_date":"2014-05","start_date":"2002-02","start_date_type":null,"primary_completion_date":"2003-10","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE2"],"tickers":["TEVA"]}